The CDSMP reduced depression by 1.37 points (PHQ-9), fatigue by 0.41, pain by 0.53, and improved sleep by 0.50 on VAS over 6 months in 6,018 patients.
Does the Chronic Disease Self-Management Program (CDSMP) improve depression, fatigue, pain, and sleep quality in individuals with chronic illnesses?
The Chronic Disease Self-Management Program (CDSMP) significantly improves patient-reported outcomes including depression, fatigue, pain, and sleep quality over 6 months in patients with chronic diseases.
Abstract Introduction The Chronic Disease Self-Management Program (CDSMP) is an evidence-based intervention developed at Stanford University over 40 years ago and has been implemented in more than 30 countries. Numerous studies have evaluated its effectiveness as it has been widely disseminated. However, over the years, evidence-based medical treatments have evolved significantly. Despite this, no study has analysed the program's effects across different patient groups beyond 2009, leaving a gap in understanding its current impact. Methods This study aimed to evaluate the 6-month effectiveness of the Chronic Disease Self-Management Program (CDSMP) among individuals with cardiovascular disease, diabetes, rheumatoid conditions, and other additional chronic illnesses. A systematic review covered the period between October 2009 and April 2024. Searches were performed across peer-reviewed databases, including PubMed, Web of Science, and Scopus, and materials on the official CDSMP website. Four separate meta-analyses were conducted, focusing on fatigue, sleep problems, and pain (measured using an 11-point Visual Analog Scale (VAS)), as well as depression, assessed using the Patient Health Questionnaire-9 (PHQ-9). Results 6,565 articles were identified, of which 228 were included in the systematic review and 20 in the meta-analysis. Across all included studies, the total number of participants was 6,018. The most prevalent chronic conditions among participants were cardiovascular diseases, type II diabetes, and rheumatoid arthritis. The meta-analyses demonstrated a significant effect of the intervention in reducing depressive symptoms (Figure 1) over six months (MD = 1.37, 95% CI: 0.94–1.80), fatigue (MD = 0.41, 95% CI: 0.22–0.60), and pain (MD = 0.53). Sleep quality improved significantly (MD = 0.50, 95% CI: 0.21–0.78). Age-stratified analyses indicated a more substantial effect of the intervention among participants aged 65 years, particularly in reducing fatigue (MD = 0.62, 95% CI: 0.16–1.08 vs. 65 years: MD = 0.34, 95% CI: 0.24–0.45) and pain (MD = 0.72, 95% CI: 0.08–1.36 vs 65 years: MD = 0.46, 95% CI: 0.30–0.61). Conclusions The results indicate that the effectiveness of the intervention varies across age groups. The Chronic Disease Self-Management Program (CDSMP) was particularly effective in reducing depressive symptoms and improving sleep quality among participants under 65, whereas individuals over 65 experienced more significant reductions in fatigue and pain. These findings underscore the long-term benefits of evidence-based self-management programs across different countries and confirm the program's scalability, making it a valuable tool for improving health outcomes in diverse ageing populations.FIG.1 Mean decrease of depression
Olszewski et al. (2025) studied this question. The CDSMP reduced depression by 1.37 points (PHQ-9), fatigue by 0.41, pain by 0.53, and improved sleep by 0.50 on VAS over 6 months in 6,018 patients.